We are pleased to announce the formation of anaRIC Biologics, a contract research organization (CRO) established through the collaboration of GMP specialist Anacura and the R&D-focused Research Institute for Chromatography (RIC). This partnership combines over 45 years of experience in GMP and R&D, aiming to support clients throughout the entire biological drug development process.

AnaRIC Biologics specializes in the analysis of complex biological compounds, such as antibodies, proteins, and peptides. By integrating RIC’s flexible and innovative R&D capabilities with Anacura’s standardized and stable GMP environment, the collaboration offers comprehensive analytical services from discovery through to marketing.

This strategic alliance underscores our commitment to providing tailored analytical solutions that meet the evolving needs of the biopharmaceutical industry.​

Read here